AtriCure CEO gifts 6,000 company shares
AtriCure, Inc. President, CEO, and Director Michael H. Carrel reported bona fide gifts totaling 6,000 shares of AtriCure common stock on March 6, 2026, consisting of separate transfers of 5,000 shares and 1,000 shares.
Rhea-AI Filing Summary
AtriCure, Inc. President, CEO, and Director Michael H. Carrel reported bona fide gifts totaling 6,000 shares of AtriCure common stock on March 6, 2026, consisting of separate transfers of 5,000 shares and 1,000 shares. No consideration was received for these gifts to his children and sibling, and his directly owned stake was reported as 778,498 shares following the gifts. He also reported indirect holdings held by his children, parents, and sibling, and disclaimed beneficial ownership of those indirect holdings except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 5,000 | $0.00 | $0.00 |
| Gift | Common Stock | 1,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. No consideration was received in connection with this gift to the reporting person's children.
- F2. No consideration was received in conjunction with this gift to the reporting person's sibling.
- F3. The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did AtriCure (ATRC) CEO Michael Carrel report in this Form 4?
What indirect AtriCure (ATRC) holdings associated with the CEO are disclosed?
AI-generated analysis. How Rhea-AI works. Not financial advice.